secwatch.observer — SEC 8-K summary
======================================

Issuer:     InfuSystem Holdings, Inc (INFU)
CIK:        0001337013
Form:       8-K
Filed at:   2026-02-27T23:59:59+00:00
Accession:  0001628280-26-012895
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InfuSystem reports record 2025 revenue $143.4M, adj. EBITDA $31.5M, net leverage 0.52x
--------------------------------------------------------------------------------

- 2025 net revenue $143.4M, up 6.3% YoY from $134.9M; seven consecutive years of record revenue.
- 2025 adjusted EBITDA of $31.5M (21.9% margin) vs $25.3M (18.8%) in 2024; cash flow from operations $24.4M.
- Patient Services revenue $86.5M (60% of total), Device Solutions $56.9M (40%); gross margin 56.0%.
- Share repurchase program: $11.0M bought back through Dec 31, 2025; $20M authorization expires June 2026.
- Net leverage 0.52x, debt/equity 0.75x, total available liquidity $58.2M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1337013/000162828026012895/0001628280-26-012895-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1337013/000162828026012895/infu-20260227.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-012895

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer